David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Shake Shack
SHAK
$3.06B
| $176M | 0.13% |
1,254,475
+1,236,911
| +7,042% | +$135M |
|
177
Amgen
AMGN
$238B
| $175M | 0.12% |
625,081
-635,803
| -50% | -$180M |
|
178
PUT
Palo Alto Networks
PANW
$292B
| $174M | 0.12% |
852,700
+158,200
| +23% | +$29.4M |
|
179
IonQ
IONQ
$18.2B
| $174M | 0.12% |
4,039,614
-3,900,091
| -49% | -$131M |
|
180
MongoDB
MDB
$34.7B
| $173M | 0.12% |
825,614
+681,185
| +472% | +$126M |
|
181
Biogen
BIIB
$32B
| $172M | 0.12% |
1,366,207
-219,365
| -14% | -$27.3M |
|
182
DexCom
DXCM
$34.8B
| $171M | 0.12% |
1,961,590
-1,120,179
| -36% | -$87.8M |
|
183
TransDigm Group
TDG
$66.4B
| $170M | 0.12% |
111,846
+48,258
| +76% | +$67.8M |
|
184
DoorDash
DASH
$96.8B
| $169M | 0.12% |
687,034
-795,974
| -54% | -$160M |
|
185
Toronto Dominion Bank
TD
$194B
| $169M | 0.12% |
2,293,046
+2,078,792
| +970% | +$136M |
|
|
186
Robinhood
HOOD
$97.2B
| $168M | 0.12% |
1,799,107
-10,856,016
| -86% | -$643M |
|
187
Brinker International
EAT
$10.6B
| $168M | 0.12% |
934,027
-462,899
| -33% | -$72.6M |
|
188
PUT
ASML
ASML
$677B
| $168M | 0.12% |
210,100
-119,700
| -36% | -$85.9M |
|
189
CALL
Eli Lilly
LLY
$1.12T
| $168M | 0.12% |
215,500
+46,600
| +28% | +$36.2M |
|
190
Welltower
WELL
$172B
| $164M | 0.12% |
1,068,586
+196,141
| +22% | +$29.3M |
|
191
Stryker
SYK
$126B
| $164M | 0.12% |
414,909
-250,396
| -38% | -$93.7M |
|
192
Colgate-Palmolive
CL
$72.6B
| $163M | 0.12% |
1,793,903
-458,259
| -20% | -$41.8M |
|
193
Honeywell
HON
$68.4B
| $163M | 0.12% |
742,371
+314,202
| +73% | +$63.6M |
|
194
PUT
Booking.com
BKNG
$158B
| $162M | 0.11% |
700,000
+125,000
| +22% | +$25.6M |
|
195
Cheniere Energy
LNG
$57.3B
| $162M | 0.11% |
665,495
-439,030
| -40% | -$102M |
|
196
PUT
Bank of Montreal
BMO
$122B
| $161M | 0.11% |
1,448,400
+435,000
| +43% | +$43.8M |
|
197
Lyft
LYFT
$6.61B
| $160M | 0.11% |
10,152,171
+6,526,787
| +180% | +$91.4M |
|
198
Boeing
BA
$169B
| $160M | 0.11% |
762,877
+737,403
| +2,895% | +$139M |
|
199
CALL
Alphabet (Google) Class A
GOOGL
$4.22T
| $160M | 0.11% |
907,000
+788,700
| +667% | +$129M |
|
200
CALL
Uber
UBER
$161B
| $159M | 0.11% |
1,706,900
-343,700
| -17% | -$28.3M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.